BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 18765202)

  • 1. Late allograft failure after heart transplantation: 2 unusual cases.
    Boilson BA; Miller DV; Pereira NL
    J Heart Lung Transplant; 2008 Sep; 27(9):1050-4. PubMed ID: 18765202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An unusual presentation of post-transplant lymphoproliferative disorder mimicking vasculitis in heart transplantation.
    Murray DL; Pereira NL; Miller DV
    J Heart Lung Transplant; 2008 Nov; 27(11):1257-61. PubMed ID: 18971100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe cardiac allograft dysfunction without endomyocardial biopsy signs of cellular rejection: incidence and management.
    Veiga Barreiro A; Crespo Leiro M; Doménech García N; Paniagua MJ; Vázquez Martul E; González Cuesta M; Ramírez C; Juffé Stein A; Castro Beiras A
    Transplant Proc; 2004 Apr; 36(3):778-9. PubMed ID: 15110660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolution of untreated mild rejection in heart transplant recipients.
    Lloveras JJ; Escourrou G; Delisle MB; Fournial G; Cerene A; Bassanetti I; Durand D
    J Heart Lung Transplant; 1992; 11(4 Pt 1):751-6. PubMed ID: 1498143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Refractory humoral cardiac allograft rejection successfully treated with a single dose of rituximab.
    Baran DA; Lubitz S; Alvi S; Fallon JT; Kaplan S; Galin I; Correa R; Courtney MC; Chan M; Spielvogel D; Lansman SL; Gass AL
    Transplant Proc; 2004 Dec; 36(10):3164-6. PubMed ID: 15686719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heart retransplantation for heart allograft failure in Chinese heart transplant recipients: NTUH experience.
    Chou NK; Chi NH; Chen YS; Yu HY; Lee CM; Huang SC; Hsu RB; Ko WJ; Lin FY; Chu SH; Wang SS
    Transplant Proc; 2006 Sep; 38(7):2147-8. PubMed ID: 16980027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of cardiac allograft rejection and response to immunosuppressive therapy with peripheral blood gene expression.
    Horwitz PA; Tsai EJ; Putt ME; Gilmore JM; Lepore JJ; Parmacek MS; Kao AC; Desai SS; Goldberg LR; Brozena SC; Jessup ML; Epstein JA; Cappola TP
    Circulation; 2004 Dec; 110(25):3815-21. PubMed ID: 15583081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late onset antibody-mediated rejection and endothelial localization of vascular endothelial growth factor are associated with development of cardiac allograft vasculopathy.
    Bayliss J; Bailey M; Leet A; Stein AN; Thomson NM; McLean CA
    Transplantation; 2008 Oct; 86(7):991-7. PubMed ID: 18852667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term immunosuppressive therapy in recurrent giant cell myocarditis in the transplanted heart: a case report.
    Aguero J; Martinez-Dolz L; Almenar L; Chirivella M; Salvador A
    Transplant Proc; 2007 Jun; 39(5):1718-9. PubMed ID: 17580231
    [No Abstract]   [Full Text] [Related]  

  • 10. Persistent histologic evidence of rejection in a heart transplant recipient without evidence of graft dysfunction.
    Nakhleh RE; Kubo SH; Olivari MT; McDonald K
    J Heart Lung Transplant; 1992; 11(1 Pt 1):37-41. PubMed ID: 1540610
    [No Abstract]   [Full Text] [Related]  

  • 11. [Myocarditis caused by Toxoplasma gondii and Aspergillus fumigatus after orthotopic heart transplantation].
    Völker H; Sigmund M; Kropff M; Hürter T; Kemnitz J; Kirkpatrick CJ; Hanrath P
    Z Kardiol; 1991 May; 80(5):359-62. PubMed ID: 1872010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of humoral immunity in acute cardiac allograft dysfunction.
    Costanzo-Nordin MR; Heroux AL; Radvany R; Koch D; Robinson JA
    J Heart Lung Transplant; 1993; 12(2):S143-6. PubMed ID: 8476884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular abnormalities and cardiomyocyte lipofuscin deposits in endomyocardial biopsy specimens of heart transplant recipients: are they related to the development of cardiac allograft vasculopathy?
    Zakliczynski M; Nozynski J; Konecka-Mrowka D; Krynicka-Mazurek A; Swierad M; Maruszewski M; Przybylski R; Zembala M
    J Thorac Cardiovasc Surg; 2009 Jul; 138(1):215-21, 221.e1-3. PubMed ID: 19577082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of human erythrocyte C4d to erythrocyte complement receptor 1 ratio in cardiac transplant recipients with acute symptomatic allograft failure.
    Lee KC; Chang CY; Chuang YC; Sue SH; Chu TW; Chen RJ; Chen SH; Wei J; Chen CH
    Transplant Proc; 2008 Oct; 40(8):2638-42. PubMed ID: 18929826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sparing immunosuppression in heart transplant recipients with severe sepsis.
    Chou NK; Ko WJ; Chi NH; Chen YS; Yu HY; Hsu RB; Fang CT; Chang SC; Lin FY; Chu SH; Wang SS
    Transplant Proc; 2006 Sep; 38(7):2145-6. PubMed ID: 16980026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Donor-specific HLA alloantibodies: long-term impact on cardiac allograft vasculopathy and mortality after heart transplant.
    Kaczmarek I; Deutsch MA; Kauke T; Beiras-Fernandez A; Schmoeckel M; Vicol C; Sodian R; Reichart B; Spannagl M; Ueberfuhr P
    Exp Clin Transplant; 2008 Sep; 6(3):229-35. PubMed ID: 18954302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolated cardiac sarcoidosis in heart transplantation.
    Chang TI; Chi NH; Chou NK; Tsao CI; Yu HY; Chen YS; Wang SS
    Transplant Proc; 2012 May; 44(4):903-6. PubMed ID: 22564580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Giant coronary aneurysms in heart transplantation: an unusual presentation of cardiac allograft vasculopathy.
    Haddad F; Perez M; Fleischmann D; Valantine H; Hunt SA
    J Heart Lung Transplant; 2006 Nov; 25(11):1367-70. PubMed ID: 17097503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heart transplant rejection treated with plasmapheresis.
    Partanen J; Nieminen MS; Krogerus L; Harjula AL; Mattila S
    J Heart Lung Transplant; 1992; 11(2 Pt 1):301-5. PubMed ID: 1315571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of cardiogenic shock caused by humoral cardiac allograft rejection.
    Saito S; Matsumiya G; Fukushima N; Sakaguchi T; Fujita T; Ueno T; Miyagawa S; Yamauchi A; Sawa Y
    Circ J; 2009 May; 73(5):970-3. PubMed ID: 19088395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.